Synaffix BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synaffix BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11290
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synaffix BV (Synaffix) is a biotechnology company that discovers and develops site-specific antibody-drug conjugates technology platforms. The company develops its products through its proprietary technology and GlycoConnect. It constructs homogenous and stable ADCs with the aid of a payload-enhancing linker technology and HydraSpace. Synaffix generates ADCs with improved therapeutic index for the treatment of various types of cancer. The company’s hydraspace offers payload enhancing linker technology and enabling dual warhead ADCs with two mechanisms of action. Its technology can also be applied for imaging controlled delivery, vaccines, and diagnostics. The company works in partnership with other companies to develop the ADC technology platform. Synaffix is headquartered in Oss, the Netherlands.

Synaffix BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synaffix BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synaffix BV, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Synaffix Raises Funds Through Series A Financing 10
Licensing Agreements 12
ADC Therapeutics Enters into Licensing Agreement with Synaffix 12
Synaffix Enters into Licensing Agreement with ADC Therapeutics 13
Synaffix BV – Key Competitors 14
Synaffix BV – Key Employees 15
Synaffix BV – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Dec 06, 2017: Synaffix Launches toxSYN, a New Platform of ADC Payloads 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Synaffix BV, Pharmaceuticals & Healthcare, Key Facts 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Deals By Therapy Area, 2012 to YTD 2018 8
Synaffix BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synaffix Raises Funds Through Series A Financing 10
ADC Therapeutics Enters into Licensing Agreement with Synaffix 12
Synaffix Enters into Licensing Agreement with ADC Therapeutics 13
Synaffix BV, Key Competitors 14
Synaffix BV, Key Employees 15

List of Figures
Synaffix BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synaffix BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synaffix BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synaffix BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arch Pharmalabs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Arch Pharmalabs Ltd (Arch Pharmalabs) is a healthcare products company that offers pharmaceutical ingredients. The company manufactures, develops and markets active APIs and intermediates. It offers products such as docetaxel anhydrous and trihydrate, amlodipine besylate, perindopril erbumin …
  • Hydro One Ltd (H):電力:M&Aディール及び事業提携情報
    Summary Hydro One Ltd (Hydro One) is a utility holding company that conducts electricity transmission and distribution in Ontario through its subsidiaries. It also undertakes telecommunications business and certain corporate activities. The company serves residential, commercial and industrial custo …
  • SciClone Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The company’s lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicate …
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Far Eastone Telecommunications Co Ltd (4904):企業の財務・戦略的SWOT分析
    Far Eastone Telecommunications Co Ltd (4904) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Electricity Generating Public Co Ltd (EGCO)-エネルギー分野:企業M&A・提携分析
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary Nicox SA is an ophthalmology company developing solutions to help maintain vision and improve ocular health. The company is engaged in the research, development and marketing investigational drugs for ophthalmological diseases. The aims to produce therapeutic products which aims to address t …
  • Baxter International Inc (BAX):企業の財務・戦略的SWOT分析
    Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析
    Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Mitsubishi Ufj Financial Group Inc:企業の戦略・SWOT・財務分析
    Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Blackbird Energy Inc (BBI):石油・ガス:M&Aディール及び事業提携情報
    Summary Blackbird Energy Inc (Blackbird Energy), formerly Blackbird Investments Inc, is an independent oil and gas exploration and development company that acquires, explores, produces and develops oil and gas properties in Western Canada. The company holds interests in Elmworth Project which concen …
  • Orange SA (ORA):企業の財務・戦略的SWOT分析
    Orange SA (ORA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • JD.com Inc:企業の戦略・SWOT・財務情報
    JD.com Inc - Strategy, SWOT and Corporate Finance Report Summary JD.com Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pacific Scientific Energetic Materials Company:企業の戦略・SWOT・財務情報
    Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report Summary Pacific Scientific Energetic Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • DHL International GmbH:企業の戦略的SWOT分析
    DHL International GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • WideMed Technologies LTD:医療機器:M&Aディール及び事業提携情報
    Summary WideMed Technologies LTD (WideMed) is a medical device company that develops and manufactures information systems for monitoring, diagnosis and analysis of sleep disorders. The company’s products include Morpheus Modules, Morpheus Hx and Morpheus Ox. Its Morpheus modules are automatic scorin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆